Myopia, also known as nearsightedness, is a prevalent condition affecting about 40% of the US population. Globally, the number of patients with myopia is projected to reach nearly 5 billion by 2050. This rapid increase is attributed to increased screen time, decreased outdoor activity, and genetic predisposition.
Children with myopia often struggle in school, sports, and social settings due to blurred vision.
Myopia occurs when the eyeball is too long, or the cornea is too curved, causing light to focus in front of the retina rather than directly on it. As a result, distant objects appear blurry while close objects remain clear. If left untreated, myopia can lead to more severe complications, such as an increased risk of retinal detachment, cataracts, and glaucoma.
Myopia cannot be reversed, but myopia management can slow its progression and reduce the risk of future eye health complications.
This treatment aims to slow the progression of nearsightedness through specialized treatments, including:
We provide customized myopia management plans to help patients maintain clear vision and reduce long-term eye health risks regardless of age.
Get the quality treatment you deserve with us.
Myopia, also known as nearsightedness, occurs when the eyeball is too long or the cornea is too curved, causing light to focus in front of the retina rather than directly on it. Distant objects appear blurry while close objects remain clear.
No. Myopia cannot be reversed. However, myopia management can slow its progression and reduce the risk of future eye health complications.
If left untreated, myopia can lead to more serious complications later in life, including an increased risk of retinal detachment, cataracts and glaucoma. Slowing progression in childhood is about long-term eye health, not just a prescription.
Myopia already affects about 40% of the US population, and globally the number of people with myopia is projected to reach nearly 5 billion by 2050. The rapid increase is attributed to increased screen time, decreased outdoor activity and genetic predisposition.
There are four: Orthokeratology (Ortho-K) overnight lenses, multifocal contact lenses, low-dose atropine eye drops, and Stellest spectacle lenses.
Stellest lenses are specialised spectacle lenses that correct myopia and slow its progression in children by an average of 71% over two years when worn consistently. In September 2025 they became the first myopia-control spectacle lens authorised by the FDA in the United States.
Low-dose atropine has been clinically proven to slow myopia progression in children. Which option suits your child depends on their eyes and lifestyle, which is what the consultation determines.
It can be. Children with myopia often struggle in school, sports and social settings because of blurred distance vision, sometimes without ever mentioning it.